+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Neglected Tropical Diseases Diagnosis Market Research Report by Service, Disease, Diagnostic Method, End-Use, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 125 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5722523
The United States Neglected Tropical Diseases Diagnosis Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Neglected Tropical Diseases Diagnosis Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Neglected Tropical Diseases Diagnosis Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Neglected Tropical Diseases Diagnosis Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Neglected Tropical Diseases Diagnosis Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Neglected Tropical Diseases Diagnosis Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Neglected Tropical Diseases Diagnosis Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Service, the market is studied across Centralized Service and POC Service.
  • Based on Disease, the market is studied across African Trypanosomiasis, Buruli Ulcer, Chagas Disease, Chikungunya, Dengue, Dracunculiasis, Echinococcosis, Foodborne Trematodiases, Leishmaniasis, Leprosy, Lymphatic Filariasis, Onchocerciasis, Rabies, Scabies, Schistosomiasis, Snakebite Envenoming, Soil-transmitted Helminth Infections, Taeniasis/Cysticercosis, and Yaws.
  • Based on Diagnostic Method, the market is studied across Conventional Method and Molecular/Modern Method.
  • Based on End-Use, the market is studied across Clinical Labs, Home Healthcare, and Hospitals /Clinics.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Neglected Tropical Diseases Diagnosis Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Neglected Tropical Diseases Diagnosis Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Neglected Tropical Diseases Diagnosis Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Neglected Tropical Diseases Diagnosis Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Neglected Tropical Diseases Diagnosis Market, including Abbott Laboratories, Bio-Rad Laboratories, Inc., Coris BioConcept SPRL, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Genome Diagnostics Pvt. Ltd., InBios International, Inc., Omega Diagnostics Group PLC, Ortho Clinical Diagnostics, Oscar Medicare Pvt. Ltd., Premier Medical Corporation Ltd., Siemens AG, Thermo Fisher Scientific Inc., and ZeptoMetrix LLC.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Neglected Tropical Diseases Diagnosis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Neglected Tropical Diseases Diagnosis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Neglected Tropical Diseases Diagnosis Market?
4. What is the competitive strategic window for opportunities in the United States Neglected Tropical Diseases Diagnosis Market?
5. What are the technology trends and regulatory frameworks in the United States Neglected Tropical Diseases Diagnosis Market?
6. What is the market share of the leading vendors in the United States Neglected Tropical Diseases Diagnosis Market?
7. What modes and strategic moves are considered suitable for entering the United States Neglected Tropical Diseases Diagnosis Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing preference for early disease identification in the United States
5.1.1.2. Rising awareness associated with neglected tropical diseases
5.1.2. Restraints
5.1.2.1. Decrease in the healthcare budget in few advancing countries
5.1.3. Opportunities
5.1.3.1. Growing development of less complicated and inexpensive diagnostic assays for tropical diseases
5.1.3.2. Increasing number of regulatory approvals
5.1.4. Challenges
5.1.4.1. Absence of standardization tools for diagnosis
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Neglected Tropical Diseases Diagnosis Market, by Service
6.1. Introduction
6.2. Centralized Service
6.3. POC Service

7. Neglected Tropical Diseases Diagnosis Market, by Disease
7.1. Introduction
7.2. African Trypanosomiasis
7.3. Buruli Ulcer
7.4. Chagas Disease
7.5. Chikungunya
7.6. Dengue
7.7. Dracunculiasis
7.8. Echinococcosis
7.9. Foodborne Trematodiases
7.10. Leishmaniasis
7.11. Leprosy
7.12. Lymphatic Filariasis
7.13. Onchocerciasis
7.14. Rabies
7.15. Scabies
7.16. Schistosomiasis
7.17. Snakebite Envenoming
7.18. Soil-transmitted Helminth Infections
7.19. Taeniasis/Cysticercosis
7.20. Yaws

8. Neglected Tropical Diseases Diagnosis Market, by Diagnostic Method
8.1. Introduction
8.2. Conventional Method
8.3. Molecular/Modern Method

9. Neglected Tropical Diseases Diagnosis Market, by End-Use
9.1. Introduction
9.2. Clinical Labs
9.3. Home Healthcare
9.4. Hospitals /Clinics

10. California Neglected Tropical Diseases Diagnosis Market
10.1. Introduction

11. Florida Neglected Tropical Diseases Diagnosis Market
11.1. Introduction

12. Illinois Neglected Tropical Diseases Diagnosis Market
12.1. Introduction

13. New York Neglected Tropical Diseases Diagnosis Market
13.1. Introduction

14. Ohio Neglected Tropical Diseases Diagnosis Market
14.1. Introduction

15. Pennsylvania Neglected Tropical Diseases Diagnosis Market
15.1. Introduction

16. Texas Neglected Tropical Diseases Diagnosis Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Product Portfolio Analysis, By Key Player
17.5. Competitive Scenario
17.5.1. Merger & Acquisition
17.5.2. Agreement, Collaboration, & Partnership
17.5.3. New Product Launch & Enhancement
17.5.4. Investment & Funding
17.5.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Abbott Laboratories
18.2. Bio-Rad Laboratories, Inc.
18.3. Coris BioConcept SPRL
18.4. DiaSys Diagnostic Systems GmbH
18.5. F. Hoffmann-La Roche Ltd
18.6. Genome Diagnostics Pvt. Ltd.
18.7. InBios International, Inc.
18.8. Omega Diagnostics Group PLC
18.9. Ortho Clinical Diagnostics
18.10. Oscar Medicare Pvt. Ltd.
18.11. Premier Medical Corporation Ltd.
18.12. Siemens AG
18.13. Thermo Fisher Scientific Inc.
18.14. ZeptoMetrix LLC

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET DYNAMICS
FIGURE 8. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET COMPETITIVE STRATEGIC WINDOW, BY SERVICE, 2030
FIGURE 12. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CENTRALIZED SERVICE, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POC SERVICE, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2022 VS 2030 (%)
FIGURE 15. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET COMPETITIVE STRATEGIC WINDOW, BY DISEASE, 2030
FIGURE 17. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY AFRICAN TRYPANOSOMIASIS, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BURULI ULCER, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHIKUNGUNYA, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DENGUE, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DRACUNCULIASIS, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ECHINOCOCCOSIS, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY FOODBORNE TREMATODIASES, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEPROSY, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RABIES, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCABIES, 2018-2030 (USD MILLION)
FIGURE 31. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SNAKEBITE ENVENOMING, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SOIL-TRANSMITTED HELMINTH INFECTIONS, 2018-2030 (USD MILLION)
FIGURE 34. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TAENIASIS/CYSTICERCOSIS, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY YAWS, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2022 VS 2030 (%)
FIGURE 37. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 38. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET COMPETITIVE STRATEGIC WINDOW, BY DIAGNOSTIC METHOD, 2030
FIGURE 39. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONVENTIONAL METHOD, 2018-2030 (USD MILLION)
FIGURE 40. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR/MODERN METHOD, 2018-2030 (USD MILLION)
FIGURE 41. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 42. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 43. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USE, 2030
FIGURE 44. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICAL LABS, 2018-2030 (USD MILLION)
FIGURE 45. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
FIGURE 46. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS /CLINICS, 2018-2030 (USD MILLION)
FIGURE 47. CALIFORNIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. FLORIDA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. ILLINOIS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. NEW YORK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. OHIO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. PENNSYLVANIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. TEXAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 55. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 56. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CENTRALIZED SERVICE, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CENTRALIZED SERVICE, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POC SERVICE, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POC SERVICE, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY AFRICAN TRYPANOSOMIASIS, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY AFRICAN TRYPANOSOMIASIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BURULI ULCER, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BURULI ULCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, BY STATE, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHIKUNGUNYA, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHIKUNGUNYA, BY STATE, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DENGUE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DENGUE, BY STATE, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DRACUNCULIASIS, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DRACUNCULIASIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ECHINOCOCCOSIS, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ECHINOCOCCOSIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY FOODBORNE TREMATODIASES, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY FOODBORNE TREMATODIASES, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEPROSY, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEPROSY, BY STATE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RABIES, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RABIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCABIES, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCABIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SNAKEBITE ENVENOMING, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SNAKEBITE ENVENOMING, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SOIL-TRANSMITTED HELMINTH INFECTIONS, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SOIL-TRANSMITTED HELMINTH INFECTIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TAENIASIS/CYSTICERCOSIS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TAENIASIS/CYSTICERCOSIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY YAWS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY YAWS, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONVENTIONAL METHOD, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONVENTIONAL METHOD, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR/MODERN METHOD, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR/MODERN METHOD, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICAL LABS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICAL LABS, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOME HEALTHCARE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS /CLINICS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS /CLINICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. CALIFORNIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 62. CALIFORNIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 63. CALIFORNIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 64. CALIFORNIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 65. CALIFORNIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. FLORIDA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 67. FLORIDA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 68. FLORIDA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 69. FLORIDA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 70. FLORIDA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. ILLINOIS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 72. ILLINOIS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 73. ILLINOIS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 74. ILLINOIS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 75. ILLINOIS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. NEW YORK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 77. NEW YORK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 78. NEW YORK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 79. NEW YORK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 80. NEW YORK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. OHIO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 82. OHIO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 83. OHIO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 84. OHIO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 85. OHIO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. PENNSYLVANIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 87. PENNSYLVANIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 88. PENNSYLVANIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 89. PENNSYLVANIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 90. PENNSYLVANIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. TEXAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 92. TEXAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 93. TEXAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 94. TEXAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 95. TEXAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 97. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 98. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 99. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 100. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 101. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 102. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET MERGER & ACQUISITION
TABLE 103. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 104. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 105. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET INVESTMENT & FUNDING
TABLE 106. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 107. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Coris BioConcept SPRL
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche Ltd
  • Genome Diagnostics Pvt. Ltd.
  • InBios International, Inc.
  • Omega Diagnostics Group PLC
  • Ortho Clinical Diagnostics
  • Oscar Medicare Pvt. Ltd.
  • Premier Medical Corporation Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix LLC

Methodology

Loading
LOADING...